Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segmentâs principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļMIR
āļāļ·āđāļāļāļĢāļīāļĐāļąāļMirion Technologies Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 29, 2020
āļāļĩāļāļĩāđāļLogan (Thomas D)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ2860
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJun 29
āļāļĩāđāļāļĒāļđāđ1218 Menlo Drive
āđāļĄāļ·āļāļATLANTA
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ30318
āđāļāļĢāļĻāļąāļāļāđ17704322744
āđāļ§āđāļāđāļāļāđhttps://www.mirion.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļMIR
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 29, 2020
āļāļĩāļāļĩāđāļLogan (Thomas D)
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Director
Mr. Brian Schopfer
Chief Financial Officer
Mr. Loic Eloy
Group President - Nuclear and Safety
Group President - Nuclear and Safety
Mr. Kenneth C. Bockhorst
Lead Independent Director
Lead Independent Director
Mr. John W. Kuo, J.D.
Independent Director
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Ms. Emmanuelle Lee
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
Mrs. Alison Ulrich
Chief Human Resources Officer
Chief Human Resources Officer
Ms. Jody A. Markopoulos
Independent Director
Mr. Eric Linn
Investor Relations
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Director
Mr. Brian Schopfer
Chief Financial Officer
Mr. Loic Eloy
Group President - Nuclear and Safety
Group President - Nuclear and Safety
Mr. Kenneth C. Bockhorst
Lead Independent Director
Lead Independent Director
Mr. John W. Kuo, J.D.
Independent Director
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
TCW Transform Systems ETF
Gabelli Love Our Planet & People ETF
Invesco S&P SmallCap Information Technology ETF
Alpha Architect U.S. Quantitative Momentum ETF
State Street SPDR S&P Kensho Future Security ETF
Invesco S&P SmallCap 600 Pure Growth ETF
Range Nuclear Renaissance Index ETF
State Street SPDR S&P 600 Small Cap Growth ETF
Vanguard S&P Small-Cap 600 Growth Index Fund
iShares S&P Small-Cap 600 Growth ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
TCW Transform Systems ETF
āļŠāļąāļāļŠāđāļ§āļ6.65%
Gabelli Love Our Planet & People ETF
āļŠāļąāļāļŠāđāļ§āļ5.64%
Invesco S&P SmallCap Information Technology ETF
āļŠāļąāļāļŠāđāļ§āļ3.27%
Alpha Architect U.S. Quantitative Momentum ETF
āļŠāļąāļāļŠāđāļ§āļ1.78%
State Street SPDR S&P Kensho Future Security ETF
āļŠāļąāļāļŠāđāļ§āļ1.44%
Invesco S&P SmallCap 600 Pure Growth ETF
āļŠāļąāļāļŠāđāļ§āļ1.36%
Range Nuclear Renaissance Index ETF
āļŠāļąāļāļŠāđāļ§āļ1.26%
State Street SPDR S&P 600 Small Cap Growth ETF
āļŠāļąāļāļŠāđāļ§āļ0.99%
Vanguard S&P Small-Cap 600 Growth Index Fund
āļŠāļąāļāļŠāđāļ§āļ0.93%
iShares S&P Small-Cap 600 Growth ETF
āļŠāļąāļāļŠāđāļ§āļ0.91%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ